In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
  • Select events

    Select Select events(s)

  • Year

    Select Year(s)

  • Resource type

    Select Resource type(s)

  • Topic

    Select Topic(s)

Filters (0)
  • Select events
  • sub-topic
  • Year
  • Resource type
  • Topic
  • Select events
  • sub-topic
  • Year
  • Resource type
  • Topic

Sponsored content

Presentations below are part of sessions sponsored by Boehringer Ingelheim

218 results for your search

ASPIRE.

Event : HFA Discoveries 2020

  • Session : Why we should embrace SGLT2 inhibitors for heart failure
  • Speaker : S Anker (Berlin,DE)
  • Sponsored by Boehringer Ingelheim & Eli Lilly and Co Alliance

COMMUNITY.

Event : HFA Discoveries 2020

  • Session : Why we should embrace SGLT2 inhibitors for heart failure
  • Speaker : M Cowie (London,GB), R Fontes Carvalho (Porto,PT), S Anker (Berlin,DE)
  • Sponsored by Boehringer Ingelheim & Eli Lilly and Co Alliance

EMBRACE.

Event : HFA Discoveries 2020

  • Session : Why we should embrace SGLT2 inhibitors for heart failure
  • Speaker : M Cowie (London,GB)
  • Sponsored by Boehringer Ingelheim & Eli Lilly and Co Alliance

EXPERIENCE.

Event : HFA Discoveries 2020

  • Session : Why we should embrace SGLT2 inhibitors for heart failure
  • Speaker : R Fontes Carvalho (Porto,PT)
  • Sponsored by Boehringer Ingelheim & Eli Lilly and Co Alliance

Why we should embrace SGLT2 inhibitors for heart failure

Event : HFA Discoveries 2020

  • Session : Why we should embrace SGLT2 inhibitors for heart failure
  • Speaker : M Cowie (London,GB), R Fontes Carvalho (Porto,PT), S Anker (Berlin,DE)
  • Sponsored by Boehringer Ingelheim & Eli Lilly and Co Alliance

10 years since RE-LY: applying innovations in anticoagulation

Event : ESC Congress 2019

  • Session : 10 years since RE-LY: applying innovations in anticoagulation
  • Speaker : E Hylek (Boston,US), H Darius (Berlin,DE)
  • Sponsored by Boehringer Ingelheim

Advancing evidence-based care in patients with type 2 diabetes: new opportunities for cardiologists.

Event : Heart Failure 2019

  • Session : Know it by heart – New opportunities for cardiologists in the Sodium-Glucose-Co-Transporter 2 (SGLT2) inhibitor era
  • Speaker : R Fontes Carvalho (Porto,PT)
  • Sponsored by Boehringer Ingelheim & Eli Lilly and Company Alliance

Antithrombotic therapy in atrial fibrillation patients post-PCI: guidance from both sides of the Atlantic

Event : ESC Congress 2019

  • Session : Antithrombotic therapy in atrial fibrillation patients post-percutaneous coronary intervention: guidance from both sides of the Atlantic
  • Speaker : C Cannon (Boston,US), G Lip (Liverpool,GB)
  • Sponsored by Boehringer Ingelheim

Antithrombotic therapy post-PCI: is your practice keeping up with the guidelines?

Event : ESC Congress 2019

  • Session : NOACs in patients undergoing cardiac procedures
  • Speaker : DJ Angiolillo (Jacksonville,US)
  • Sponsored by Boehringer Ingelheim

Antithrombotic therapy post-PCI: practical tips for challenging scenarios

Event : ESC Congress 2019

  • Session : NOACs in patients undergoing cardiac procedures
  • Speaker : J ten Berg (Nieuwegein,NL)
  • Sponsored by Boehringer Ingelheim

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are